Uveal Melanoma and Brachytheraphy: Long-term Outcomes.

F

Federico II University

Status

Completed

Conditions

Uveal Melanoma

106 Ruthenium Plaque Brachytherapy

Treatments

Radiation: 106 Ruthenium plaque brachytherapy

Study type

Observational

Funder types

Other

Identifiers

NCT04577742

2020/106

Details and patient eligibility

About

This study investigated the visual and anatomical outcomes, tumor control, tumor recurrence, distant metastasis and cancer free survival in patients affected by uveal melanoma and undergoing Ru-106 plaque brachytherapy between February 2011 and March 2020

Enrollment

350 patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria